BioCentury
ARTICLE | Company News

Sage, H3 in deal covering cancer pharmacogenomic profiling

December 20, 2012 1:32 AM UTC

H3 Biomedicine Inc. (Cambridge, Mass.) partnered with not-for-profit Sage Bionetworks (Seattle, Wash.) to develop a "pipeline" of pharmacogenomic profiling data to help verify and identify drug respon...